Literature DB >> 20717938

Monocytes from children with clinically stable cystic fibrosis show enhanced expression of Toll-like receptor 4.

Nina C Sturges1, Matthew E Wikström, Kaye R Winfield, Samantha E Gard, Siobhain Brennan, Peter D Sly, John W Upham.   

Abstract

SUMMARY: Lung disease in patients with cystic fibrosis (CF) is characterized by recurrent bacterial respiratory infections and intense airway inflammation. Pattern recognition receptors such as Toll-like receptor 2 (TLR2) and TLR4 identify bacterial pathogens and activate the innate immune response. We therefore hypothesized that increased expression of these receptors would be found on circulating immune cells from children with CF. A cohort of 66 young children (median age 3 years) with CF was studied and compared to both healthy controls (n = 14) and children without CF who were being investigated for recurrent respiratory infections (non-CF disease controls; n = 17) of a similar age. Surface expression of TLR2 and TLR4 on peripheral blood monocytes was analyzed using flow cytometry. TLR4 expression was significantly higher in patients with CF compared to healthy controls (P = 0.017) and non-CF disease controls (P = 0.025) but did not vary according to the presence or absence of pulmonary infection with Gram-negative or Gram-positive bacteria (P = 0.387) in the CF group. In contrast, TLR2 expression was similar across all three study groups (P = 0.930). The increased surface expression of TLR4 seen in young children with CF appears to be related to having CF per se and not related to current pulmonary infection. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717938     DOI: 10.1002/ppul.21230

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  14 in total

Review 1.  Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.

Authors:  Maaike Cockx; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

Review 2.  Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.

Authors:  Romina Fiorotto; Mariangela Amenduni; Valeria Mariotti; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-05       Impact factor: 5.187

Review 3.  Azithromycin use in patients with cystic fibrosis.

Authors:  N Principi; F Blasi; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-17       Impact factor: 3.267

4.  Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages.

Authors:  Sheetal Kotrange; Benjamin Kopp; Anwari Akhter; Dalia Abdelaziz; Arwa Abu Khweek; Kyle Caution; Basant Abdulrahman; Mark D Wewers; Karen McCoy; Clay Marsh; Slade A Loutet; Ximena Ortega; Miguel A Valvano; Amal O Amer
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

5.  Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis.

Authors:  Emanuela M Bruscia; Ping-Xia Zhang; Ayano Satoh; Christina Caputo; Ruslan Medzhitov; Ambika Shenoy; Marie E Egan; Diane S Krause
Journal:  J Immunol       Date:  2011-05-18       Impact factor: 5.422

6.  The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.

Authors:  Romina Fiorotto; Ambra Villani; Antonis Kourtidis; Roberto Scirpo; Mariangela Amenduni; Peter J Geibel; Massimiliano Cadamuro; Carlo Spirli; Panos Z Anastasiadis; Mario Strazzabosco
Journal:  Hepatology       Date:  2016-10-27       Impact factor: 17.425

Review 7.  Cystic Fibrosis Lung Immunity: The Role of the Macrophage.

Authors:  Emanuela M Bruscia; Tracey L Bonfield
Journal:  J Innate Immun       Date:  2016-06-24       Impact factor: 7.349

8.  Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis.

Authors:  Stéphane Jouneau; Mélanie Bonizec; Chantal Belleguic; Benoit Desrues; Graziella Brinchault; Jeanne Galaine; Jean-Pierre Gangneux; Corinne Martin-Chouly
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

9.  Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases.

Authors:  Julie Chesné; Richard Danger; Karine Botturi; Martine Reynaud-Gaubert; Sacha Mussot; Marc Stern; Isabelle Danner-Boucher; Jean-François Mornex; Christophe Pison; Claire Dromer; Romain Kessler; Marcel Dahan; Olivier Brugière; Jérôme Le Pavec; Frédéric Perros; Marc Humbert; Carine Gomez; Sophie Brouard; Antoine Magnan
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

Review 10.  Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation.

Authors:  Carla M P Ribeiro; Bob A Lubamba
Journal:  Int J Mol Sci       Date:  2017-01-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.